Stay updated on LN-145 + Pembrolizumab in Transitional Cell Cancer Clinical Trial
Sign up to get notified when there's something new on the LN-145 + Pembrolizumab in Transitional Cell Cancer Clinical Trial page.
Latest updates to the LN-145 + Pembrolizumab in Transitional Cell Cancer Clinical Trial page
- Check7 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.1%
- Check14 days agoChange DetectedThe website has updated the contact details section for the study, clarifying who to contact for questions and providing information on the study's location, with a revision from v2.12.2 to v2.13.2.SummaryDifference3%
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe website has added a 'Show less' feature while removing extensive details about participant groups, interventions, and various data fields available for download.SummaryDifference4%
- Check36 days agoChange DetectedSeveral key health-related resources have been removed, including links to rare disease information, Dailymed, and various government health websites.SummaryDifference0.4%
- Check43 days agoChange DetectedThe website has been updated to version 2.12.2, adding several new resources related to rare diseases and clinical trials, while removing the option to show less information and the previous revision note.SummaryDifference5%
- Check50 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference0.1%
Stay in the know with updates to LN-145 + Pembrolizumab in Transitional Cell Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LN-145 + Pembrolizumab in Transitional Cell Cancer Clinical Trial page.